
0.6711 Delayed Data As of Jun 02 | ![]() Today’s Change | 0.50 Today|||52-Week Range 2.41 | +0.61% Year-to-Date |
SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $8.4M |
Cyclacel Pharmaceuticals, Inc. 200 Connell Drive Berkeley Heights New Jersey 07922 |
Spiro Rombotis | President, Chief Executive Officer & Director |
Paul McBarron | Secretary, Chief Operating & Financial Officer |
Mark Kirschbaum | Chief Medical Officer & Senior Vice President |